ABBV Research and Charts

ABBV - AbbVie Inc (Healthcare: Drug Manufacturers - General)

Projected Earnings Date: 2026-05-06 (Delayed quote data 2026-03-24)

Last 205.12	Change ⇑ +0.19 (+0.09%)	Volume 6,983,314
	Open 202.84	High 206.01	Low 201.80

8EMA (Daily) 210.83	40EMA (Daily) 221.46	50EMA (Daily) 222.08	STO (Daily) 5.822	MACD Hist (Daily) -2.440
8EMA (Weekly) 217.409	40EMA (Weekly) 215.72	50EMA (Weekly) 212.81	STO (Weekly) 44.714	MACD Hist (Weekly) -3.346


Company Profile
AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.